The North American Spine Society is committed to quality patient care through promotion of patient safety and prevention of medical errors.
NASS monitors a variety of government and other resources for patient safety related notices that may be useful to our members. Information
from these notices is also archived on the NASS website at https://www.spine.org/Pages/ResearchClinicalCare/PatientSafety/SpineSafetyAlerts.
aspx. This information is provided as a service for information and education only.
Spine Safety Notices
Adverse reactions or quality problems experienced with the use of these products may be reported to the FDA’s
Med Watch Adverse Event Reporting program either online, by regular mail or by fax.
• Online: www.fda.gov/medwatch/report.htm
• Regular Mail: use postage-paid, pre-addressed Form FDA 3500 at: www.fda.gov/medwatch/getforms.htm.
Mail to address on the pre-addressed form.
• Fax: (800) FDA-0178
DRUG/DEVICE/OTHER NOTIFICATION TYPE FULL REPORT:
Alvogen | Clindamycin Injection ADD-Vantage Vials Recall: Lack of Sterility Assurance https://goo.gl/BeszyU
Eliquis (apixaban) 5 mg Tablets (Lot #HN0063) Recall: Bottle labeled as Eliquis 5 mg was
found to contain Eliquis 2. 5 mg tablets
Alert Warning Cautionary Notice
(High Impact) (Moderate impact) (Low Impact)
We’ll follow you anywhere...
Are you an active social media user? Let us know! Contact
us on any of our social media accounts, and we will
follow you! We are committed to providing a
two-way communication with our members
across a wide array of social media
platforms. See an outlet we should be
using? Contact email@example.com
and let us know.
@NASSspine NASS.Spine @NASSPics